Autopsy report · NCT03052270

Arabin Pessary Combine With Vaginal Progesterone Compare With Vaginal Progesterone Alone to Prevent Preterm Delivery in Singleton Pregnancies

“Former PI Left the Institution”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 11 months before it stopped.
• 57 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

University of Illinois at Chicago

Sponsor type

University, hospital or other

Conditions

Focus: Prevent Preterm Delivery; Incidental Short Cervix at Mid-trimester

Interventions

Arabin Pessary

Participants

57

Sites

1

Countries

United States

Trials that died the same way

• Pediatric Pilot Study: Irrigation and Scrubbing in Facial and Scalp Wounds
  “PI left the institution” (94% match in meaning)
• Impact of Strength and Power Training on Golf Performance and Swing Biomechanics
  “PI has left the institution.” (90% match in meaning)
• Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma
  “PI leaving institution” (88% match in meaning)
• PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer
  “Due to PI leaving the institution” (87% match in meaning)
• Oscillatory Versus Non-Oscillatory Nasal Continuous Airway Pressure Neonatal Respiratory Support
  “PI has left Institution” (87% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.